Depression News and Research

Latest Depression News and Research

Study unveils ways new moms can lose baby weight after childbirth

New moms who returned to work soon after delivery, had childcare help, breastfed, and did not experience postpartum depression were the ones most able to lose the baby weight within 6 months of giving birth, according to a new research study.

18 Aug 2010

Psychological support from health visitors prevents depression after child birth: Study

The world's first ever analysis of data from a full scale clinical trial in adults shows that training Health Visitors to assess and psychologically support mothers after childbirth can prevent the development of depression over the following year.But the substantial reduction in the number of NHS health visitors was identified by researchers as a key issue for the health and well-being of mums.

18 Aug 2010

Study finds black patients receive fewer opoid medications than whites

Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.

18 Aug 2010

Holotranscobalamin protein may be key to early detection of cognitive decline

B vitamins-B-6, B-12 and folate-all nourish the brain. But much remains to be discovered about the relation between these essential nutrients and our brainpower.

18 Aug 2010

Brain stimulation may improve thinking in people with schizophrenia

Mild electrical stimulation to the brain could improve thinking and reduce auditory hallucinations in people with schizophrenia and schizo-affective disorder, researchers from the University of New South Wales (UNSW) have found.

17 Aug 2010

Air quality along US Gulf Coast improves after stoppage of oil leak

The oil spill along the United States Gulf Coast poses health risks to volunteers, fishermen, clean-up workers and members of coastal communities, according to a new commentary by UCSF researchers who spent time in the region and are among the first to look into health problems caused by the oil spill. The good news, the authors say, is that one of the risk factors, coastal air quality, is improving now that the oil leak has been stopped.

17 Aug 2010

Study discovers multiple effects of SSRIs on cells

A new discovery about selective serotonin reuptake inhibitors (SSRIs) suggests that these drugs, which are used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. In a research report published in the August 2010 issue of GENETICS, researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why different people taking the same drug may experience different effects, and could also lead to new types of drugs altogether.

17 Aug 2010

Depressive Cognition Scale questions can detect cognitive symptoms of early depression

A diagnostic test of eight short questions designed by Jaclene Zauszniewski from the Frances Payne Bolton School of Nursing at Case Western Reserve University can be used to detect depressive thinking patterns that lead to clinical depression in women who care for an adult family member with a serious mental illness.

17 Aug 2010

Antidepressant alleviates depression in peri- and postmenopausal women: Study

An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher.

17 Aug 2010

Cortex second-quarter net loss decreases to $0.04 per share

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $2,454,000, or $0.04 per share, for the quarter ended June 30, 2010, compared with a net loss applicable to common stock of approximately $2,778,000, or $0.06 per share, for the corresponding prior year period.

16 Aug 2010

Medforma unveils new Internet-based wellness platform

Nearly 80 percent of health care costs are spent on treating preventable diseases. And most of this burden falls on employers and employees. To help employers reduce these expenses while improving the health of their workforces, St. Paul-based Medforma Inc., today unveiled the next-generation of its Internet-based wellness platform called Health Portrait™.

16 Aug 2010

Johns Hopkins Professor develops ‘CAPABLE’ study to identify solutions on health challenges

In Baltimore City, dozens of older adults are now aging safely in their homes, thanks to the work of Assistant Professor Sarah L. Szanton, PhD, CRNP, at the Johns Hopkins University School of Nursing.

16 Aug 2010

Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness

Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.

16 Aug 2010

Menopause is not the end of women's love life

Menopause doesn't have to signal the end of a woman's love life. In fact, most women can enjoy even better sex after their reproductive years if they follow some healthy advice. Sex is good exercise and slows the aging process, so it's not only permissible but also smart to keep it a central part of one's lifestyle.

16 Aug 2010

Adverse effects in childhood lead to immune impairment later in life

The emotional pains we suffer in childhood can lead to weakened immune systems later in life, according to a new study.Based on this new research, the amount of this immune impairment even enhances that caused by the stress of caregiving later in life."What happens in childhood really matters when it comes to your immune response in the latter part of your life," explained Janice Kiecolt-Glaser, professor of psychology and psychiatry at Ohio State University. She explained her work at the annual meeting of the American Psychological Association in San Diego.

16 Aug 2010

CeNeRx BioPharma raises $13 million through Series C financing to support TriRima Phase II trial

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds to conduct a Phase II trial of its improved formulation of its novel antidepressant TriRima™.

13 Aug 2010